Corrigendum to “Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis” [Eur J Cancer 47 (12) (2011) 1826–1836]

2012 ◽  
Vol 48 (3) ◽  
pp. 407
Author(s):  
Stephen J. Clarke ◽  
Sonia Yip ◽  
Chris Brown ◽  
Guy A. van Hazel ◽  
David T. Ransom ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase Ii ◽  
Advanced Colorectal Cancer ◽  
Phase Ii Study ◽  
Meta Analysis ◽  
Single Agent ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy

Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis

2011 ◽  
Vol 47 (12) ◽  
pp. 1826-1836 ◽  
Author(s):  
Stephen J. Clarke ◽  
Sonia Yip ◽  
Chris Brown ◽  
Guy A. van Hazel ◽  
David T. Ransom ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase Ii ◽  
Advanced Colorectal Cancer ◽  
Phase Ii Study ◽  
Meta Analysis ◽  
Single Agent ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy

A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)

2010 ◽  
Vol 29 (5) ◽  
pp. 1038-1044 ◽  
Author(s):  
José María Viéitez ◽  
Manuel Valladares ◽  
Ignacio Peláez ◽  
Luis de Sande González ◽  
Jesús García-Foncillas ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Randomized Phase Ii ◽  
Line Chemotherapy

S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102)

2016 ◽  
Vol 21 (4) ◽  
pp. 705-712 ◽  
Author(s):  
Yuji Miyamoto ◽  
Akihito Tsuji ◽  
Hiroaki Tanioka ◽  
Soichiro Maekawa ◽  
Hirofumi Kawanaka ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Multicenter Phase ◽  
Line Chemotherapy

Multicenter Phase II Study of Gemcitabine and Oxaliplatin (GEMOX) as Second-Line Chemotherapy in Colorectal Cancer Patients Pretreated with 5-Fluorouracil plus Irinotecan

Oncology ◽  
2006 ◽  
Vol 70 (2) ◽  
pp. 106-114 ◽  
Author(s):  
N. Ziras ◽  
A. Potamianou ◽  
I. Varthalitis ◽  
K. Syrigos ◽  
S. Tsousis ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Multicenter Phase ◽  
Colorectal Cancer Patients ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document